DHA Enterprise Wide CSO Amendment 1

Amendment 01: Updates Section 14 of the CSO.

1. Agency Name

Defense Health Agency (DHA)

2. Issuing Acquisition Office

Defense Health Agency Contracting Activity (DHACA)

3. Title

DHA Enterprise-Wide Commercial Solutions Opening (CSO)

4. Announcement Type

This announcement establishes the general competitive procedures the Government will utilize to award FAR-based contracts pursuant to 10 U.S.C. § 3201 and 10 U.S.C. § 3458, as amended, other transaction authority agreements pursuant to 10 U.S.C. § 4021 and 4022, to include but not limited to basic, applied, and advanced research projects, prototyping and production agreements, and procurements for experimental purposes (pursuant to 10 U.S.C. § 4023, as amended) to deliver commercial solutions pertaining to the General Scope of this CSO (pursuant to 10 U.S.C. § 3458).

5. CSO Number

HT003826SC005

6. Active Period

07 August 2026 through 06 August 2027

7. Overview

DHA is a combat support agency that serves as a force multiplier for the joint services by optimizing lethality through warfighter medical readiness. DHA delivers the full spectrum of health services in garrison and during combat operations to ensure warfighters are medically ready to deploy, fully supported throughout operations and rapidly returned to duty. As the foundation of an integrated health enterprise, DHA provides joint medical capabilities across a mission-ready health system worthy of the Department of War (DoW), geographic combatant commands, the Military Services, their families, and all beneficiaries.
The risk of near-peer competitor conflict heightens the expediency of a cultural and operational shift to meet DoW requirements. Known constraints impacting the ability to meet mission requirements include continued operations under a flat fiscal top line, significantly decreased buying power, decreased civilian personnel and Uniformed Personnel operating within the direct care system, and the continued increase of total and per episode care cost in the purchased care system. To enable the DoW to prevent and prevail in combat operations, DHA must overcome these constraints to deliver medical readiness to the warfighter at scale, on time, and with precision.

Consistent with Executive Order 14271 (Ensuring Commercial, Cost-Effective Solutions in Federal Contracts), DHA will actively prioritize commercially available, cost-effective solutions over custom, government-unique developments to achieve readiness goals more rapidly and efficiently.
DHA currently has three Portfolio Acquisition Executives (PAE) responsible for Medical